Pharmaceuticals

  1. Industry Sectors
  2. Pharmaceuticals
Fake clinical tests data GP struck off: A disciplinary panel hears the doctor falsely claimed a … BBC15:07
Big Pharma Can’t Resist Big Mergers. Here’s Why. Barron's Online11:05
GSK to divest Chiron Behring Vaccines to Bharat Biotech Pharmaceutical Technology11:18
The Brexit implications for the UK pharma packaging industry European Pharmaceutical Manufacturer08:59
UCB signs research deal with King’s College London PMLiVE12:21
Healthcare And Biotechnology Dashboard - Update Seeking Alpha17:22
Cipla to acquire 11.71% stake in Wellthy Therapeutics The Times of India17:00
Teva reconnecting to Israel's startup ecosystem Globes16:45
Catalent receives P&G External Business Partner of the Year Award Manufacturing Chemist16:11
Trump's drug price plan mixed bag for benefit managers Fox News15:39
Biotech in post-Brexit Britain: the future for the UK’s pharma-innovation engine? pharmaphorum14:18
EMA suspends fenspiride medicines due to heart rhythm risks PharmaTimes14:08
Choose date and time: ×
NEW in the last 5 minutes
Novo Nordisk's soon-to-be-released insulin pens will connect to Glooko's diasend platform MobiHealthNews21:32
In the last hour
Mexico's ruling party lawmakers urge capping drug prices Reuters.co.uk21:02
In the last 2 hours
Maintain ‘Neutral’ on Dr Reddy’s Labs, PT at Rs 2,540 – Motilal Oswal The Financial Express20:24
Ale salvaged from 1886 shipwreck may find new life at Upstate NY brewery Post-Standard, New York20:02
In the last 4 hours
"Inadequate": Johnson And Johnson Implant Victims Object To Compensation Package NDTV.com18:53
Supreme Court refuses to stay CCI Monsanto probe The Times of India18:29
Bristol-Myers drives into CAR-T therapies The Economist Intelligence Unit18:26
CRISPR technology creates pluripotent stem cells that are 'invisible' to the immune system News-Medical.Net18:15
In the last 6 hours
The Prognosis For Kura Oncology Seeking Alpha17:24
Healthcare And Biotechnology Dashboard - Update Seeking Alpha17:22
Cipla to acquire 11.71% stake in Wellthy Therapeutics The Times of India17:00
Perigord announces the release of GLAMS CMO European Pharmaceutical Review17:00
Teva reconnecting to Israel's startup ecosystem Globes16:45
Hunt for immunotherapy combinations turns up success in kidney cancer BioPharma Dive16:39
Biotech firm awarded for approach to drug development European Pharmaceutical Review16:30
Bayer Bags Full Vitrakvi Rights As Lilly Signs Off Loxo Buy Scrip Pharma Intelligence16:24
BioMarin Is Carrying The Biggest Target On Its Back, Morningstar Says Scrip Pharma Intelligence16:24
Troubled Realm Therapeutics Selling Assets, Delisting From London AIM Scrip Pharma Intelligence16:24
Study Documents How Price of TNF Inhibitors Rose After New Competition Center for Biosimilars16:23
Catalent receives P&G External Business Partner of the Year Award Manufacturing Chemist16:11
CRISPR corrects DMD in mice for a year in Sarepta-supported study FierceBiotech16:08
CRISPR gene editing makes stem cells 'invisible' to immune system Medical Xpress16:01
MedImmune will cease to exist after 30 years in-PharmaTechnologist.com15:45
Trump's drug price plan mixed bag for benefit managers Fox News15:39
US regulator seeks additional details on $4.2bn Boston Scientific-BTG deal Verdict Medical Devices15:38
Pipeline Watch: Phase III Starts In Prostate Cancer, C Diff Diarrhea Scrip Pharma Intelligence15:33
In the last 8 hours
Fake clinical tests data GP struck off: A disciplinary panel hears the doctor falsely claimed a … BBC15:07
Sanofi appoints new chief digital officer Science|Business15:07
Saama adds new AI-based capabilities to its analytics platform Outsourcing-Pharma.com14:51
Tech is advancing, but uncertainty creates an ‘opposing effect’ to positive movement Outsourcing-Pharma.com14:51
EMA implored to improve trial reporting, with over 50% of trials still missing results Outsourcing-Pharma.com14:51
Merck’s Keytruda set to become new standard of care for renal cancer patient population after gaining edge over… Global Data14:51
Diverging from FDA, Health Canada Announces Suffix-Free Biologic and Biosimilar Naming Convention Center for Biosimilars14:22
Eli Lilly Hints That It May Pursue "Branded Biosimilars" of Its Own Products Center for Biosimilars14:22
Medicare coverage for CAR-T drugs on the horizon pharmaphorum14:18
Keytruda combo set to become “standard of care” in kidney cancer pharmaphorum14:18
Biotech in post-Brexit Britain: the future for the UK’s pharma-innovation engine? pharmaphorum14:18
What's in the Cards for Amarin (AMRN) This Earnings Season? Nasdaq14:10
Seeing through the spin Fabian Society14:09
EMA suspends fenspiride medicines due to heart rhythm risks PharmaTimes14:08
UCB to form a research satellite facility within King’s College London PharmaTimes14:08
Innovate UK awards AKLRD £675,000 for osteoarthritis drug PharmaTimes14:08
Darolutamide shows promise for treatment of prostate cancer PharmaTimes14:08
£675k boost for innovative osteoarthritis drug clinical trial University of Liverpool13:45
Earlier today
Beating the flu Pharmafile13:23
Sygnature Discovery makes key appointments Pharmaceutical Field12:54
Astellas' Xtandi "significantly improves" progression-free survival in advanced hormone-sensitive prostate cancer Pharmafile12:52
Finance Watch: 5AM, Longevity Close Funds, New Incubators Launch To Support Early-Stage Companies Scrip Pharma Intelligence12:52
Merck testing Keytruda combinations for prostate cancer PharmaTimes12:48
Opdivo/Yervoy combo successful in castration-resistant prostate cancer PharmaTimes12:38
Rexulti falls short of goal in late-stage bipolar disorder studies PharmaTimes12:38
Iran: US Using Sanctions against Pharmaceutical Industry Fars News Agency12:37
Policy to improve access and foster price competition for generics European Pharmaceutical Review12:28
Motif Bio reaches deal to reduce repayment burden Web Financial Group12:28
UCB signs research deal with King’s College London PMLiVE12:21
Incyte's Undervalued as Pipeline Progresses MorningStar.com12:20
Bayer takes control of Loxo duo as Lilly closes takeover pharmaphorum12:17
SUNY Cobleskill Students Hope To Extract 133-Year-Old Beer Spectrum News12:09
Smoking may limit immune system's ability to fight cancer, study shows Pharmafile12:01
What if you could diagnose endometriosis with a tampon? MIT Technology Review12:00
‘Simply unacceptable’: FDA warns against illegitimate opioids in-PharmaTechnologist.com11:53
Merck Group and Pfizer announce positive results for combo therapy for RCC Pharmaceutical Technology11:48
Pharma group expands into Cheshire site TheBusinessDesk.com11:40
Braving the big, bad B word Manufacturing Chemist11:39
Bavencio+Inlyta combo boosts progression-free survival in advanced kidney cancer Pharmafile11:31
GSK to divest Chiron Behring Vaccines to Bharat Biotech Pharmaceutical Technology11:18
FDA issues warning letter to doctor for illegally marketing unapproved device Compelo11:17
CStone to study avapritinib in trial for GI stromal tumours Drug Development Technology11:08
Big Pharma Can’t Resist Big Mergers. Here’s Why. Barron's Online11:05
KEYTRUDA results published for advanced renal cell carcinoma Pharmaceutical Field10:53
Boyds consultancy expands into Alderley Park Pharmaceutical Field10:53
Researchers activate gene to reverse depression in mice Pharmafile10:51
FDA warning: Tainted sexual enhancement products MassLive.com10:40
Drug combination may treat advanced kidney cancer AniNews.in10:36
Bayer, Orion prep challenge in prostate cancer market PMLiVE10:30
Emergex secures R&D facility in Oxfordshire Manufacturing Chemist10:28
MSD's Keytruda combo therapy significantly improves survival in advanced renal cell carcinoma Pharmafile10:21
Trial could unlock new prostate cancer sales for Pfizer/Astellas’ Xtandi pharmaphorum10:16
First Amendment Musings About Compelled Speech Drug & Device Law10:06
Lilly closes $8bn Loxo Oncology acquisition Pharmaceutical Technology09:47
German drugmaker Merck sets up Israel incubator to tap into chip, sensor tech The Times of Israel09:41
Cipla Chief Calls For Invigorating Focus On Repurposed Drugs Scrip Pharma Intelligence09:40
EU MDR does not draw distinctions Manufacturing Chemist09:28
NICE recommends Roche’s breast cancer drug pertuzumab Pharmaceutical Technology09:17
Gov't to Invest 3 Trillion Won in Biotech This Year KBS World Radio09:10
The Brexit implications for the UK pharma packaging industry European Pharmaceutical Manufacturer08:59
Advancing electronic prescribing Pharmaceutical Field08:32
Medicines Discovery Catapult and the high impact medicines discovery Pharmaceutical Field08:32
4 shares with dividend growth potential? Barclays PLC, Tesco PLC, AstraZeneca plc and BP plc Investomania08:28
Condemning the Pulwama attack, National science institute cancels foundation day The Times of India07:41
Arvelle Therapeutics raises $180m in Series A financing European Biotechnology News07:29
Can USFDA all-clear for Duvvada earn Dr Reddy’s stock a rerating? The Economic Times06:57
Drug combinations could become first-line treatment for metastatic kidney cancer News-Medical.Net05:50
Dr Reddy's Laboratories gains 5% as USFDA lifts warning on Duvvada plant The Business Standard05:26
BUZZ-India's Dr.Reddy's gains most in nearly 13 weeks after U.S FDA report Reuters05:08
Korea to spend 2.93t won to develop bio tech in 2019 The Korea Herald05:04
Patented IU discovery to treat ARDS has been optioned to Theratome Bio News-Medical.Net04:49
Mega drugs distribution centres, key to curbing drug abuse and misuse, says Lagos PSN chairman The Sun News, Nigeria03:35
Stocks in the news: YES Bank, TechM, Dr Reddy's Labs, Biocon, Jet Airways and DHFL The Economic Times03:26
Shire Solid But Hemophilia Challenges Looming? Scrip Pharma Intelligence03:17
Blackstone likely to assist Ranjan Pai acquire Medanta The Times of India01:42
Karnataka High Court refuses to let Sanofi India bite in corruption case with BARC Bangalore Mirror00:44
Why the Bionomics share price rocketed 75% higher today The Motley Fool (Australia)00:30

About our Pharma news...

NewsNow aims to be the world's most accurate and comprehensive pharmaceutical news aggregator, bringing you the latest headlines from the best pharma sites and other key national and regional news sources. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication. N.B. Relevance is automatically assessed so some headlines not qualifying as pharma news might appear - please feel free to contact us regarding any persistent issues. [Read more]

NewsNow Classifieds » Jobs » Top Searches

view more
© Copyright 1997 - 2019 NewsNow Publishing Limited. All rights reserved.

No account? Sign up!

  • Bookmark your favourite topics and create your very own NewsNow page.
  • Save publication preferences and your reading history for quick reference.
  • Take this with you whenever and wherever you sign in!
Site View
Publication filters

Headline Density

  • We may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, please read our Privacy Policy and Cookie Policy, which also explains how you can control cookies. By clicking "OK" or continuing to use this site, you agree to allow such ads to be shown and cookies to be set.
Sorry, no headlines or news topics were found. Please try different keywords.
Rest of site